- Author:
Shu-Yuan LIU
1
;
La-Gen WAN
1
;
Lin-Lin GAO
2
;
Yun-Yuan KONG
1
;
Xin LI
1
;
Zhang-Lin ZHANG
3
Author Information
- Publication Type:Journal Article
- MeSH: COP9 Signalosome Complex; Cell Differentiation; Cell Line, Tumor; Down-Regulation; Humans; Leukemia, Promyelocytic, Acute; metabolism; Multiprotein Complexes; metabolism; Peptide Hydrolases; metabolism; Tretinoin; pharmacology
- From: Journal of Experimental Hematology 2015;23(5):1277-1281
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the expression of CSN complex (COP9 signal some subunits) in the patients with acute promyelocytic leukemia (APL) and its significance in the ATRA-induced APL differentiation.
METHODSUsing the NB4 cells as a model, morphologic observation and myeloid differentiation marker CD11b detection were used to monitor ATRA-induced APL differentiation, the expression of CSN complex in cell differentiation was detected by Western blot and reverse transcription real time fluorescent quantitative PCR (RT-qPCR) method. RT-qPCR was also used to detect the relative expression level of COP9 signalosome subunits in the APL patients and remission after treatment.
RESULTSATRA could obviously enhance CD11b expression; the cell morphology showed obvious differentiation characteristics. During the differentiation, the expression of COP9 signalosome subunits was down-regulated by ATRA. Meanwhile, the CSN expression level in newly diagnosed APL patients was much higher than that in controls (non-leukemia) (P < 0.05). The level of CSN expression was obviously down-regulated when APL patients achieved complete remission.
CONCLUSIONThe high CSN expression level in APL patients can be down-regulated by ATRA. CSN complex may have a significant effect on the pathogenesis and therapy of APL.